|
|
Article: Big decline in breast cancer rates: a new study finds a link to a drop in combination hormone therapy use--should you quit HT?(hormone therapy)
- Article from:
- Women's Health Advisor
- Article date:
- February 1, 2007
CopyrightCOPYRIGHT 2007 Belvoir Media Group, LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Breast cancer rates have been declining in recent years and provocative new research suggests part of the reason may be due to women quitting hormone therapy (HT) in 2002, after a major clinical trial found an increased risk of invasive breast cancer among older women taking the estrogen/progestin combination Prempro. Researchers from the M.D. Anderson Cancer Center in Houston, Texas told the annual San Antonio Breast Cancer Symposium (SABC) in December their data showed a major drop in breast cancer rates--seven percent--between 2002-2003, especially for estrogen receptor positive (ER-positive) breast cancers, tumors fueled by estrogen.
While most cancers take ...